PGHL vs WANBURY: Stock Comparison

PROCTER & GAMBLE HEALTH L vs WANBURYUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. PROCTER & GAMBLE HEALTH L shows a higher ROE, a higher dividend yield and faster revenue growth, while WANBURY shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

PGHL leads 10; WANBURY leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

PGHLWANBURY

Valuation lens

What price are you paying?

Market CapContext only
₹9,379 Cr
₹866 Cr
P/E RatioWANBURY has the lower reading
26.43x
0x
P/B RatioWANBURY has the lower reading
17.98x
0x
EPSPGHL has the higher reading
₹57.92
₹0.93
Book ValueContext only
₹316.01
₹41.34
Dividend YieldPGHL has the higher reading
3.45%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹9,379 Cr vs ₹866 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 26.43x
P/B Ratio
WANBURY has a lower P/B
0x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹0.93
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 0%
Revenue Growth (TTM YoY)
PGHL has faster revenue growth
19.1% vs -19.2%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 0%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
0.61% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricPGHLWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricPGHLWANBURY
Live Price₹5,660₹246.2
Day Change-1.69%1.17%
Volume7,25551,910
52-Week High₹6,975₹358.85
52-Week Low₹4,707₹161.5
Distance from 52W High-18.85%-31.39%

Valuation

MetricPGHLWANBURY
Market Cap₹9,379 Cr₹866 Cr
P/E Ratio26.43x0x
P/B Ratio17.98x0x
EPS₹57.92₹0.93
Book Value₹316.01₹41.34
Dividend Yield3.45%0%

Growth

MetricPGHLWANBURY
Revenue Growth (TTM YoY)19.1%-19.2%
EPS Growth (TTM YoY)54.6%0%
Qtr Sales Growth-74.17%0.61%
Qtr Profit Growth-70.59%-85.06%

Profitability & Leverage

MetricPGHLWANBURY
ROE62.32%45.78%
ROCE92.1%25.06%
Net Margin23.22%10.17%
Operating Margin31.99%13.81%
Debt to Equity0x1.49x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricPGHLWANBURY
Promoter Holding0%34.36%
FII Holding6.33% 0.13 pp0.89% 0.3 pp
DII Holding12.44% 1.23 pp0.06% 0.06 pp
Public Holding29.42% 1.11 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: PROCTER & GAMBLE HEALTH L and WANBURY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.